CS logo
small CS logo
George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus

New Britain, Connecticut, United States
Medical center in New Britain, Connecticut
100 Grand St 1st Flr, New Britain, CT 06052

About George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus


"A multispecialty community and teaching hospital providing quality health care services to the residents of Greater New Britain, Connecticut."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gynecologic Oncology Group
10
Celgene
7
Radiation Therapy Oncology Group
6
Alliance for Clinical Trials in Oncology
4
Bristol-Myers Squibb
3
Gilead Sciences
3
Millennium Pharmaceuticals, Inc.
3
Pfizer
3
Eastern Cooperative Oncology Group
2
Genzyme, a Sanofi Company
2
Puma Biotechnology, Inc.
2
Total Rows: 19

Clinical Trials at George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus


During the past decade, George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 34 clinical trials were completed, i.e. on average, 425% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years4411221111448888Started TrialsCompleted Trails20152016201720180246810
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
1993-04-01
Completed
1,929
Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
1999-12-01
Completed
515
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
2003-03-01
Completed
100
Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
2005-02-01
Completed
27
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
2005-05-01
Completed
55
Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
2005-01-01
Completed
81
Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
2005-10-01
Unknown status
2,000

Rows per page:

1–53 of 53

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus" #1 sponsor was "Gynecologic Oncology Group" with 10 trials, followed by "Celgene" with 7 trials sponsored, "Radiation Therapy Oncology Group" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Aptuit" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGynecologic OncologyGroup: 10Gynecologic OncologyGroup: 10Celgene: 7Celgene: 7Radiation TherapyOncology Group: 6Radiation TherapyOncology Group: 6Alliance for ClinicalTrials in Oncology: 4Alliance for ClinicalTrials in Oncology: 4Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3Gilead Sciences: 3Gilead Sciences: 3MillenniumPharmaceuticals, Inc.: 3MillenniumPharmaceuticals, Inc.: 3Pfizer: 3Pfizer: 3Eastern CooperativeOncology Group: 2Eastern CooperativeOncology Group: 2Genzyme, a Sanofi Company: 2Genzyme, a Sanofi Company: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 23National CancerInstitute (NCI): 23NRG Oncology: 6NRG Oncology: 6Cancer and LeukemiaGroup B: 2Cancer and LeukemiaGroup B: 2Aptuit: 1Aptuit: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Children's Oncology Group: 1Children's Oncology Group: 1Eastern CooperativeOncology Group: 1Eastern CooperativeOncology Group: 1Instituto Grifols, S.A.: 1Instituto Grifols, S.A.: 1Medical Research Council: 1Medical Research Council: 1Medivation, Inc.: 1Medivation, Inc.: 1

Clinical Trials Conditions at George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus


According to Clinical.Site data, the most researched conditions in "George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus" are "Fallopian Tube Cancer" (5 trials), "Ovarian Cancer" (5 trials), "Lung Cancer" (4 trials), "Multiple Myeloma" (4 trials) and "Primary Peritoneal Cavity Cancer" (4 trials). Many other conditions were trialed in "George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus" in a lesser frequency.

Clinical Trials Intervention Types at George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus


Most popular intervention types in "George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus" are "Drug" (46 trials), "Biological" (12 trials), "Radiation" (9 trials), "Other" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Lenalidomide" (5 trials), "Paclitaxel" (5 trials), "Placebo" (4 trials), "cetuximab" (4 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.

Clinical Trials Genders at George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus


The vast majority of trials in "George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus" are 40 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus


Currently, there are NaN active trials in "George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 28Phase 3: 28Phase 2: 24Phase 2: 24Phase 1: 2Phase 1: 2Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 43Completed: 43Terminated: 5Terminated: 5Active, not recruiting: 4Active, not recruiting: 4Unknown status: 1Unknown status: 1